跳至主要内容
临床试验/NL-OMON44456
NL-OMON44456已完成不适用

Evaluation of the LatellaTM Knee Implant System for Medial Osteoarthritis Pain Reduction (Latella-2 Study) - LATELLA-2

Cotera Inc.0 个研究点目标入组 54 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Cotera Inc.
入组人数
54

研究概览

简要总结

Trial is onging in other countries

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - History of pain for at least 6 months due to medial osteoarthritis, with failure
  • of pain relief from non*operative therapy OR from arthroscopic treatment for
  • medial osteoarthritis (see exclusion criteria for excluded procedures)
  • - Age: 30 * 70 years
  • - Weight:  Less than 136 kg
  • - Kellgren*Lawrence scores: Grades 2*3
  • - Baseline KOOS pain score of * 60
  • - Baseline medial knee pain Numerical Rate Scale (NRS) (while walking) score * 4
  • - Willing and able to understand and sign the informed consent

排除标准

  • * Varus angle > 10 degrees (mechanical axis)
  • * Active Flexion > 140 degrees
  • * Joint flexion contracture > 10 degrees
  • * Contralateral knee pain (Baseline medial knee pain NRS (while walking) score * 3)
  • * Osteoporosis or other condition (e.g., hyperthyroidism, Paget*s disease, scurvy) that could compromise bone quality
  • * Permanent implant in or around the knee joint
  • * Rheumatoid arthritis
  • * Osteoarthritis in non-knee joint of the lower limb or lower back that impacts activities of daily living
  • * Immunosupressive disorders (e.g., diabetes)
  • * Chronic (6 months or longer) steroid use (with the exception of inhaled steroids)
  • * History of heterotopic ossification
  • * Ligament instability
  • * Joint instability
  • * Symptomatic evidence of moderate to severe OA in the lateral and/or patellofemoral compartments
  • * Lateral osteophytes that would underlie implant region (diagnosed via x-ray)
  • * Free floating bodies
  • * Post-traumatic osteoarthritis
  • * Arthroscopy within the last 3 months
  • * Meniscal debridement within the last 6 months
  • * Prior anterior cruciate ligament reconstruction
  • * Tight Iliotibial Band or Iliotibial Band Syndrome
  • * Femoral or tibial bony deformity
  • * Disease affecting the connective tissue or muscle
  • * Continued participation in competitive or high-impact sports (e.g.,Tegner score >6)
  • * Less than 5 year history free of cancer
  • * Less than 5 year history free of primary bone tumors
  • * History of stroke, upper limb or lower limb motor disorders
  • * Bleeding diathesis
  • * Chronic use of anticoagulants (with the exception of aspirin)
  • * Known metal ion allergy to titanium alloy, aluminum, or vanadium alloy
  • * Absolute or relative contraindication for MRI
  • * Substance abuse (drug or alcohol)
  • * For women of childbearing potential: pregnant, or planning to become pregnant during the course of the clinical investigation
  • * Litigation for or workers compensation for musculoskeletal injuries or disorders
  • * Are currently participating in, or have been recently exited from (within 30 days of enrollment in this study), or plan to be enrolled in another clinical study for a device or drug that may impact participation or outcome of this study
  • * Has a condition, disorder or other factor that, in the investigator*s opinion, would interfere with study participation

研究者

发起方
Cotera Inc.

相似试验